InVitria, Inc.

InVitria develops, manufactures, and markets recombinant, scalable and sustainable products that improve manufacturing and formulation for cell and gene therapy, vaccines, biopharmaceuticals, CAR T cell therapy, stem cells, medical devices, and regenerative medicines. Source (opens in a new tab)

Headquarters

US